Filter Results:
(137)
Show Results For
- All HBS Web
(137)
- News (19)
- Research (110)
- Events (2)
- Multimedia (1)
- Faculty Publications (41)
Show Results For
- All HBS Web
(137)
- News (19)
- Research (110)
- Events (2)
- Multimedia (1)
- Faculty Publications (41)
- 27 Mar 2012
- First Look
First Look: March 27
find emissions to be less under cap-and-trade, with technology choice driving the vast majority of the difference. Download the paper: http://www.hbs.edu/research/pdf/12-079.pdf Lords of the Harvest: Third-Party Signaling and Regulatory... View Details
Keywords: Carmen Nobel
- 01 Mar 2004
- News
Drug Imports a Hot Topic at Alumni Health-Care Conference
FDA Commissioner Mark B. McClellan doesn’t approve of Americans buying low-cost prescription drugs from Canada or over the Internet. But he understands what drives them to do so. At the HBS Health Industry Alumni Association’s fourth... View Details
- 01 Mar 2023
- News
Is AI OK?
regulatory approval by next spring; and he is in the process of raising $5 million—every penny of which will go toward building a bias-free bank. “I want to create a model where everyone, irrespective of... View Details
- 03 Dec 2015
- Op-Ed
How "New Nuclear" Power Could Save the Planet—If Regulators Would Allow It
test and development facilities in multiple countries. We can re-engineer regulatory processes to radically lower costs and shorten approval times by testing full-scale prototypes before licensing. We can... View Details
- 30 Aug 2006
- Op-Ed
The Compensation Game
compared this trend to the soaring increase during this period in the compensation of other "stars," such as top baseball, basketball, and football players. Reports about the high pay of star athletes are often greeted with awe and View Details
Keywords: by Lucian Bebchuk & Rakesh Khurana
- 01 Jun 2010
- News
M.I.A. Boards
socialite Dina Merrill, who sat on the board for eighteen years and served on the compensation committee that approved CEO Richard Fuld’s $484 million in salary, stock options, and bonuses from 2000 to 2007. John Helyar, coauthor of... View Details
- 31 Jan 2017
- First Look
First Look at New Research: January 31, 2017
Abstract—The Food and Drug Administration approves new medical devices after in-depth reviews of safety and effectiveness data. Some have advocated for shorter review times to encourage innovation. We evaluated whether View Details
Keywords: Carmen Nobel
- 01 Mar 2007
- News
Daniel Vasella
(twenty years in the United States), and the other is the solidity of the patent. Regarding length, it’s a sensitive point. If we have delays in FDA regulatory approval because more questions are being... View Details
- 04 Aug 2014
- Op-Ed
Why Small-Business Lending Is Not Recovering
recently went by with no new bank charters issued by the Federal Deposit Insurance Corporation (FDIC), the first time that happened in the agency's 80-year history. Perhaps the most compelling cyclical factor tightening the loan spigot is the concern that increased... View Details
- 22 Feb 2016
- Research & Ideas
The ‘Mother of Fair Trade’ was an Unabashed Price Protectionist
Trade Act, which people widely believed was approved as a result of lobbying by the pharmacists. Gleason later said of working on the survey, “I left my store one day with only a toothbrush for baggage. I didn’t get back for six weeks. I... View Details
- 25 Feb 2014
- First Look
First Look: February 25
employee morale, followed by business relations and reputation, and then regulatory relations. I find that who initiated the bribery act, how it was detected, and how the firm responded after detection are all associated with the impact... View Details
Keywords: Sean Silverthorne
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 12 Aug 2002
- Research & Ideas
‘Let the Buyer Beware’ Doesn’t Protect Investors
The American regulatory agencies, described by Henry Kaufmann as "...less than robust... Understaffed, under-funded, and badly fragmented," have been, in his words, "slow to recognize some of the more serious abuses"... View Details
Keywords: by D. Quinn Mills
- 30 Mar 2010
- First Look
First Look: March 30
regulatory policy-making is shared in the EU, but is primarily the responsibility of local governments in the U.S. Thus, in some important areas, regulatory policy-making is more centralised in the EU. The... View Details
Keywords: Sean Silverthorne
- 05 Feb 2013
- First Look
First Look: Feb. 5
The FDA approvals of novel therapeutics were seen as signs in the personalized medicine community of real progress in the growth of personalized medicine. The FDA's approval of such drugs, along with... View Details
Keywords: Sean Silverthorne
- 01 Dec 2008
- News
No Easy Fix for the Financial Crisis
the last minute to the Friday morning schedule of HBS fall reunion participants, who nearly overflowed Burden. While the panelists at all three sessions brought different perspectives to the crisis, a consensus emerged that lax regulatory... View Details
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
companies like Frazier and Merck got from the President. Their companies have products dependent on government approvals and major regulatory issues before Congress and the administration. Given these... View Details
Keywords: by Bill George
- 01 Mar 2023
- News
The Latest Model
Hurder, who then headed to a coffee shop and began scribbling equations on a pad of paper. (The team has worked remotely from the outset, with Hurder based in Pasadena, California, and Barrera in Jersey City, New Jersey.) In the end, Prysm designed a bespoke economic... View Details
- 01 Dec 2019
- News
The Race Against Resistance
unsuccessfully. Kimble points to San Francisco–based Achaogen, which filed for bankruptcy last April despite securing regulatory approval for one of its antibiotic treatments in 2018. Given the catch-22s of... View Details
Keywords: Lisa Scanlon Mogolov
- 24 Sep 2020
- News
The Race for a Vaccine
around the world. Of those, 36 were in human testing and two, touted by China and Russia, had been approved for limited use, though experts cautioned that both vaccines needed further testing. Most attention has been focused on Moderna... View Details